Brain natriuretic peptide: Difference between revisions
| Line 1: | Line 1: | ||
==Background== | ==Background== | ||
*Biologically active metabolite of proBNP (released from ventricles in response to increased volume/pressure) | |||
*Utility is controversial and may not affect patient centered outcomes<ref>Carpenter CR et al. BRAIN NATRIURETIC PEPTIDE IN THE EVALUATION OF EMERGENCY DEPARTMENT DYSPNEA: IS THERE A ROLE? J Emerg Med. 2012 Feb; 42(2): 197–205.</ref> | |||
*May be trended to gauge treatment response in acute decompensated CHF | |||
*May have false negative with isolated diastolic dysfunction | |||
==Values and Diagnosis== | |||
{{BNP value}} | {{BNP value}} | ||
Revision as of 12:07, 20 July 2019
Background
- Biologically active metabolite of proBNP (released from ventricles in response to increased volume/pressure)
- Utility is controversial and may not affect patient centered outcomes[1]
- May be trended to gauge treatment response in acute decompensated CHF
- May have false negative with isolated diastolic dysfunction
Values and Diagnosis
Brain natriuretic peptide (BNP)[2]
- Measurement
- <100 pg/mL: Negative for acute CHF (Sn 90%, NPV 89%)
- 100-500 pg/mL: Indeterminate (Consider differential diagnosis and pre-test probability)
- >500 pg/mL: Positive for acute CHF (Sp 87%, PPV 90%)
- Combination of BNP with clinician judgment 94% sensitive 70% specific (compared to 49% sn and 96% spec clinical judgement alone) [3]
NT-proBNP[4][5][6]
- <300 pg/mL → CHF unlikely
- CHF likely in:
- >450 pg/mL in age < 50 years old
- >900 pg/mL in 50-75 years old
- >1800 pg/mL in > 75 years old
Differential Diagnosis
Elevated BNP
- CHF/ACS/Cardiogenic shock
- Pulmonary embolism
- Pulmonary hypertension
- Renal failure
- Left ventricular hypertrophy
- Sepsis[7]
- Subarachnoid hemorrhage
- Liver cirrhosis[8]
See Also
External Links
- Pediatric Emergency Playbook Podcast: Big Labs, Little People
- http://lifeinthefastlane.com/ccc/brain-natriuretic-peptide-bnp/
References
- ↑ Carpenter CR et al. BRAIN NATRIURETIC PEPTIDE IN THE EVALUATION OF EMERGENCY DEPARTMENT DYSPNEA: IS THERE A ROLE? J Emerg Med. 2012 Feb; 42(2): 197–205.
- ↑ Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347(3):161-167. doi:10.1056/NEJMoa020233.
- ↑ McCullough et al. B-Type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from breathing not properly (BNP) multinational study. Circulation. 2002:DOI: 10.1161/01.CIR.0000025242.79963.4
- ↑ Januzzi JL, van Kimmenade R, Lainchbury J, et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur Heart J. 2006 Feb. 27(3):330-7.
- ↑ Kragelund C, Gronning B, Kober L, Hildebrandt P, Steffensen R. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med. 2005 Feb 17. 352(7):666-75.
- ↑ Moe GW, Howlett J, Januzzi JL, Zowall H,. N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective randomized multicenter IMPROVE-CHF study. Circulation. 2007 Jun 19. 115(24):3103-10.
- ↑ Nikolaos I. Nikolaou, Constantin Goritsas, Maria Dede, Nikolaos P. Paissios, Michalis Papavasileiou, Amalia T. Rombola, Angeliki Ferti, Brain natriuretic peptide increases in septic patients without severe sepsis or shock, European Journal of Internal Medicine, Volume 18, Issue 7, 2007, Pages 535-541, ISSN 0953-6205, https://doi.org/10.1016/j.ejim.2007.01.006.
- ↑ Radvan M, Svoboda P, Radvanová J, Stumar J, Scheer P. Brain natriuretic peptide in decompensation of liver cirrhosis in non-cardiac patients. Hepatogastroenterology. 2009;56(89):181-185.